Organon USA Inc. and Akzo Nobel N.V.

A class action lawsuit has been settled against the drug companies for improperly monopolizing the US market. The class claimed the companies prevented them from access to low-cost, generic equivalents of Remeron. The antitrust settlement will award $36 million to Nebraska consumers who purchased the prescription antidepressant Remeron. (Mar-18-05) [SOUTHWEST NEBRASKA NEWS] [SETTLEMENT CLAIM FORM]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right to submit your complaint.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help